Direct Biologics, LLC, a late-stage biotechnology company leveraging its regenerative medicine platform using extracellular vesicles (EVs) secreted from bone marrow-derived mesenchymal stem cells to...
EVERSANA, a leading provider of commercialization services to the life science industry, announced a partnership with ChemoMouthpiece, LLC to support the launch and commercialization...
BD, a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) market approval for the BD Onclarity HPV Assay to...
PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, announced that Nick Anderson, Ph.D, has joined as Vice President of Regulatory...
Drugmaker Eli Lilly & Co announced that the FDA has issued a complete response letter, meaning it has not granted accelerated approval for amyloid-clearing...
